baber/WOPTO huggingface dataset:
Patent AU-2014334373-B2 (AU)
Title: Method of providing markings to precious stones including gemstones and diamonds, and markings and marked precious stones marked according to such a method
Inventor: HUI KOON CHUNG
IPC: G01N21/87
Filed: 2014-05-22
Granted: 2019-03-14
Abstract: An identifiable mark on a portion of a polished facet of a surface of an article and being identifiable by an optical magnifying viewing device, said identifiable mark comprising a nano-structure formed by a two-dimensional or a three-dimensional lattice of a plurality of discrete nanometer sized recessed or protruded entities, wherein said entities are arranged within a predefined region of said polished facet in a predetermined arrangement in relation to each other and such that an outer interface surface between the facet of the article and air is formed and an inner interface surface between the facet of the article and air is formed. Said predetermined arrangement of said entities is non-uniform and non-periodic arrangement, and wherein said entities are sized and shaped so as to cause optical scattering upon reflection of incident light and the distance from the inner interface surface to the outer interface surface is greater than the amplitude of the non-marked portion of said polished face. Upon reflection of incident light having one or more predetermined wavelengths by said lattice at a predetermined angle of incidence to said lattice, interference due to scattering of light from said lattice is induced such that said reflected light has a variation in intensity providing one or more local maxima of one or more wavelengths. Said mark is identifiable by way of an optical magnifying viewing device inclined at a requisite viewing angle such that a local maxima is detected.
Patent AU-2014394157-B2 (AU)
Title: Absorbent core
Inventor: BURVALL ANGELICA
IPC: A61F13/45
Filed: 2014-05-15
Granted: 2017-01-12
Abstract: The invention relates to an absorbent core (3), intended for use in an absorbent product such as a panty liner. The core (3) comprises an absorbent material and a superabsorbent material. The core (3) has a first extension in a longitudinal direction and a second extension in a transverse direction, and the core has a longitudinal central line (A) extending through the core, located between a first longitudinal portion (I) and a second longitudinal portion (II). The first and second longitudinal portions (I; II) are symmetric about the longitudinal central line (A). The core has a head portion (al), an intermediate portion (a2) and a rear portion (a3) extending in a longitudinal direction of the core. The head portion (al) comprises mirror imaged first circular segment portions (11; 11') and first edge lines (13; 13') to which the circular segment portions (11, 11') transition. The intermediate portion (a2) comprises mirror imaged first convex edge portions (15; 15'). The rear portion (a3) comprises second edge lines (17; 17') tapering towards a rear end (T5) and the central line (A) of the core in an angle (γ).
Patent AU-2015201961-B2 (AU)
Title: Method of treating anal incontinence
Inventor: HAVERFIELD MAXWELL
IPC: A61F2/48
Filed: 2015-04-18
Granted: 2017-06-08
Abstract: A method of treating anal incontinence in a patient comprising: establishing a pathway in tissue of the patient extending about the anal sphincter, wherein said pathway extends from a left pathway end laterally left and posterior to the anus, through the perineum, to a right pathway end laterally right and posterior to the anus, and wherein the step of establishing said pathway comprises: making a left buttock incision in the patient's left buttock at said left pathway end; making a right buttock incision in the patient's right buttock at said right pathway end; making an incision in the posterior vaginal wall that extends into the perineum; establishing a left passage of said pathway extending between said left buttock incision and said vaginal incision; and establishing a right passage of said pathway extending between said right buttock incision and said vaginal incision; implanting an elongate flexible support member in and extending along said pathway to support the anal sphincter, wherein the elongate flexible support member comprises a central portion and exactly two elongate extension portions extending from the central portion.
Patent AU-2015238448-B2 (AU)
Title: Method and device for applying Dynamic Range Compression to a Higher Order Ambisonics signal
Inventor: BOEHM JOHANNES
IPC: H04S3/00
Filed: 2015-03-24
Granted: 2019-04-18
Abstract: Dynamic Range Control (DRC) cannot be simply applied to Higher Order Ambisonics (HOA) based signals. A method for performing DRC on a HOA signal comprises transforming the HOA signal to the spatial domain, analyzing the transformed HOA signal, and obtaining, from results of said analyzing, gain factors that are usable for dynamic compression. The gain factors can be transmitted together with the HOA signal. When applying the DRC, the HOA signal is transformed to the spatial domain, the gain factors are extracted and multiplied with the transformed HOA signal in the spatial domain, wherein a gain compensated transformed HOA signal is obtained. The gain compensated transformed HOA signal is transformed back into the HOA domain, wherein a gain compensated HOA signal is obtained.
Patent AU-2015324390-B2 (AU)
Title: Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
Inventor: CHICHLOWSKI MACIEJ
IPC: A23L33/10
Filed: 2015-09-02
Granted: 2020-04-09
Abstract: The present disclosure a method and nutritional composition for improving the microbiome and metabolic profile of a pediatric subject, which includes administering to a pediatric subject a composition having up to about 7 g/100 kCal of a protein or protein equivalent source; up to about 7 g/100 kCal of a fat or lipid source; at least about 5 g/100 kCal of a carbohydrate; at least about 0.05 mg/100 kCal of bacterial metabolites; and either a probiotic or a prebiotic composition, or both.
Patent AU-2015330441-B2 (AU)
Title: Composition comprising a polymer and a switch initiator
Inventor: LAM PETER KWOK HING
IPC: A61F5/445
Filed: 2015-10-08
Granted: 2019-11-21
Abstract: Disclosed is a composition including a polymer and a switch initiator. The composition can be switched from a first liquid state to a second adhesive state by activation of the switch initiator. The composition has in the first liquid state a complex viscosity |η*| below 0.4 MPa s; and the composition has in the second adhesive state a second repeated peel force above 1 N/25mm.
Patent AU-2015371251-B2 (AU)
Title: Inhibitors of cyclin-dependent kinase 7 (CDK7)
Inventor: GRAY NATHANAEL S
IPC: C07D487/04
Filed: 2015-12-23
Granted: 2020-06-11
Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or preventing proliferative diseases (e.g., cancers (e.g., leukemia, acute lymphoblastic leukemia, lymphoma, Burkitt's lymphoma, melanoma, multiple myeloma, breast cancer, Ewing's sarcoma, osteosarcoma, brain cancer, neuroblastoma, lung cancer, colorectal cancer), benign neoplasms, diseases associated with angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g., cyclin-dependent kinase 7 (CDK7)), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.
Patent AU-2015412489-B2 (AU)
Title: Traveling unit and work vehicle
Inventor: SHO TOMOYOSHI
IPC: B62D55/12
Filed: 2015-10-22
Granted: 2019-05-02
Abstract: A traveling body (20) is provided with a drive wheel (21) and a crawler track link (1). The drive wheel (21) comprises a plurality of drive wheel teeth (21eb) and tooth grooves (21ea) adjacent to the drive wheel teeth (21eb). The crawler track link (1) comprises protrusions (2b) that mesh with the drive wheel teeth (21eb). The protrusions (2b) have a height h that is equal to or greater than the depth d of the tooth grooves (21ea).
Patent AU-2016212315-B2 (AU)
Title: Vehicle control system and method
Inventor: BROCKLEY NICK
IPC: B60W40/105
Filed: 2016-01-15
Granted: 2019-10-10
Abstract: PAT14-189WO1 / P300934GB B-578 SPEC 37 VEHICLE CONTROL SYSTEM AND METHODEmbodiments of the present invention provide a vehicle control system comprising a speed control system, the speed control system being configured automatically to attempt to cause a vehicle to operate in accordance with a target speed value by causing a first vehicle speed value determined according to a first predetermined method to become or be maintained substantially equal to the predetermined target speed value at least in part by causing application of positive drive torque to one or more wheels by means of a powertrain, wherein the speed control system is configured to impose a constraint on the amount of driving torque that may be demanded of the powertrain in dependence on the target speed value and a second vehicle speed value determined according to a second predetermined method, said a second predetermined method being based on the mean speed of the driven wheels of the vehicle.
Patent AU-2016213867-B2 (AU)
Title: Rapid establishment and/or termination of substantial steady-state drug delivery
Inventor: ALESSI THOMAS R
IPC: A61K9/22
Filed: 2016-08-12
Granted: 2017-12-07
Abstract: The present invention is directed to treatment methods for a disease or condition, in a subject in need of such treatment, that provide alternatives to treatment by injection that give, relative to treatment by injection, improved treatment outcomes, 100% treatment compliance, reduced side effects, and rapid establishment and/or termination of substantial steady-state drug delivery. The method typically includes providing continuous delivery of a drug from an implanted osmotic delivery device, wherein substantial steady-state delivery of the drug at therapeutic concentrations is typically achieved within about 7 days or less after implantation of the osmotic delivery device in the subject and the substantial steady-state delivery of the drug from the osmotic delivery device is continuous over a period of at least about 3 months. In one embodiment, the present invention is directed to treatment of type 2 diabetes mellitus using incretin mimetics.
Patent AU-2016244055-B2 (AU)
Title: Electronic device including an externally-mounted heat pipe
Inventor: Yeini Avraham
IPC: H05K7/20
Filed: 2016-03-17
Granted: 2018-03-01
Abstract: An electronic device including a housing having a container and a cover. The cover defines an opening. The electronic device also includes a circuit board positioned within the container. The circuit board includes an electrical component that is aligned with the opening. The electronic device further includes a heat pipe mounted to the cover. A portion of the heat pipe extends into the opening of the cover to thermally communicate with the electrical component.
Patent AU-2016244121-B2 (AU)
Title: High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
Inventor: COWLEY AARON B
IPC: A23L2/52
Filed: 2016-04-04
Granted: 2020-11-05
Abstract: Disclosed herein are oxalate inducing enzymes with pH and thermal stability and methods of using for oxalate related conditions for in food processing.
Patent AU-2016245958-B2 (AU)
Title: CD20 therapies, CD22 therapies, and combination therapies with a CD19 Chimeric Antigen Receptor (CAR) - expressing cell
Inventor: BITTER HANS
IPC: A61K39/00
Filed: 2016-04-08
Granted: 2021-09-09
Abstract: The invention provides compositions and methods for treating diseases associated with expression of CD19, e.g., by administering a recombinant T cell comprising the CD19 CAR as described herein, in combination with one or more B-cell inhibitors, e.g., inhibitors of one or more of CD1O, CD20, CD22, CD34, CD123, FLT-3, ROR1, CD79b, CD179b, or CD79a. The disclosure additionally features novel antigen binding domains and CAR molecules directed to CD20 and CD22, and uses, e.g., as monotherapies or in combination therapies. The invention also provides kits and compositions described herein.
Patent AU-2016272881-B2 (AU)
Title: Solid dosage forms of palbociclib
Inventor: IBRAHIM FADY MAKRAM LOUIZ
IPC: A61K31/519
Filed: 2016-05-24
Granted: 2019-04-11
Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water- soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.
Patent AU-2016275135-B2 (AU)
Title: Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units
Inventor: WONG SERENA HANYING
IPC: A61N1/02
Filed: 2016-06-10
Granted: 2021-04-01
Abstract: A system and method for providing therapy to a patient can include a monitoring unit and a therapy unit. The monitoring unit can have a user interface and one or more sensors to measure patient data. The therapy unit can have a stimulator for generating electrical stimulation and a microcontroller for controlling the generation of the electrical stimulation based on the measured patient data.
Patent AU-2016341403-B2 (AU)
Title: GITR agonists
Inventor: DESCHAGHT PIETER
IPC: C07K16/28
Filed: 2016-10-24
Granted: 2023-08-03
Abstract: The present invention relates to immunoglobulin single variable domains that bind GITR and more in particular to polypeptides that comprise or essentially consist of one or more such immunoglobulin single variable domains; to nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the polypeptides of the present invention enhance the biological activity of GITR.
Patent AU-2016353693-B2 (AU)
Title: Methods and arrangements for managing allocation of uplink resources regarding remaining data blocks of an uplink transmission
Inventor: BERGQVIST JENS
IPC: H04W72/14
Filed: 2016-11-10
Granted: 2019-04-04
Abstract: A network node (600; 110) comprised in a wireless communication network (100) is for managing allocation of uplink resources regarding remaining data blocks of an uplink transmission performed by a device (800; 120). The network node (600; 110) sends (201; 501), to the device (800; 120), first allocation information that identifies uplink resources that have been allocated to the device (800; 120) for uplink transmission of said remaining data blocks. The remaining data blocks being associated with the allocated uplink resources, respectively. The network node (600; 110) also sends (203; 502), to the device (800; 120), and the device (800; 120) receives, a second allocation information that identifies one or more of said allocated uplink resources identified by the first allocation information, wherein said second allocation information further identifies one or more of said remaining data blocks as data blocks to be excluded by the device (800; 120).
Patent AU-2016363006-B2 (AU)
Title: SLC45A2 peptides for immunotherapy
Inventor: LIZEE GREGORY
IPC: A61K38/00
Filed: 2016-12-02
Granted: 2021-02-18
Abstract: Provided are SLC45A2 peptides that bind to MHC I (HLA-A2) on melanoma cells or other antigen-presenting cells and are recognized by T-cell receptors on T cells. The SLC45 A2 peptides may be therapeutically used to treat a cancer, such as a cutaneous melanoma, uveal melanoma, a mucosal melanoma, or a metastatic melanoma. Methods for expanding a population of T cells that target SLC45A2 are also provided.
Patent AU-2016385211-B2 (AU)
Title: Photovoltaic element
Inventor: KOMATSU NOBUAKI
IPC: H01G9/20
Filed: 2016-12-27
Granted: 2019-10-03
Abstract: The purpose of the present invention is to improve the power generation efficiency of a photovoltaic element. Provided is a tandem-type photovoltaic element that uses titanium dioxide and silicon dioxide, wherein a silicon dioxide particulate which constitutes a first photovoltaic layer 24 made of silicone dioxide is thinly dispersed on a charge exchange layer 23 that is made of Pt and that has an uneven surface and on a first conductive film 22 that is made of FTO and that also has an uneven surface. Due to this configuration, a photovoltaic element with high power generation efficiency can be obtained.
Patent AU-2017210572-B2 (AU)
Title: Monitoring and recording implantable silicon active pressure transducer
Inventor: CRIVELLI ROCCO
IPC: G01L9/04
Filed: 2017-08-03
Granted: 2018-11-15
Abstract: An implantable active pressure transducer including a pressure sensing element and associated sensor circuitry together enclosed within an innermost glass packaging. The pressure sensing element is anodically bonded to the innermost packaging substantially aligned with an opening defined therein. An outermost biocompatible metal packaging forms a cavity divided into first and second chambers by an intermediate partition. The innermost packaging is disposed within the first chamber without physically directly contacting or being fixed to the outermost packaging. A barrier plate is hermetically sealed to the intermediate partition to hermetically isolate the battery and communication circuitry from a pressure transmitting fluid. Inductive coupling is used to communicate data detected by the pressure sensing element internally within the implant. Ilof 3 (0) (0Y
Patent AU-2017214424-B2 (AU)
Title: Process for producing a creamer
Inventor: FRIES LENNART
IPC: A23C11/00
Filed: 2017-02-03
Granted: 2020-12-17
Abstract: The present invention relates to a process for producing a creamer comprising; (a) i) incorporating a mineral into an oil component by high shear mixing to provide a first composition; and ii) mixing the first composition with an aqueous component to provide a second composition; or (b) i) incorporating a mineral into an aqueous component to provide a first composition; and ii) mixing the first composition with an oil component to provide a second composition; iii) homogenizing the second composition from step ii) of (a) or (b) to provide an oil-in- water emulsion.
Patent AU-2017261073-B2 (AU)
Title: Vacuum cleaner
Inventor: HYUN KIETAK
IPC: A47L9/16
Filed: 2017-05-02
Granted: 2019-07-11
Abstract: Disclosed is a vacuum cleaner comprising: a cleaner body; and a dust collecting apparatus disposed on the cleaner body. The dust collecting apparatus comprises: a first cyclone which is provided inside an outer case, filters dust and foreign materials from the air flowed in from the outside, allows the air from which the dust and foreign materials have been filtered to flow therein, and has a mesh filter; a second cyclone which is accommodated inside the first cyclone and is for separating fine dust from the air flowed into the first cyclone; and a rotating unit which covers a part of the first cyclone and can rotate in at least one direction with respect to the first cyclone. The rotating unit comprises: a filler which is disposed so as to cover the mesh filter and extends along the vertical direction of the mesh filter; and a scraper which is provided on the inner surface of the filler facing the outer surface of the mesh filter and is for scraping down the dust and foreign materials accumulated on the mesh filter when the rotating unit rotates.
Patent AU-2017267634-B2 (AU)
Title: Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
Inventor: SIEGWART DANIEL J
IPC: C07C309/01
Filed: 2017-05-16
Granted: 2022-01-27
Abstract: The present disclosure provides one or more amino lipids such as an amino lipids containing a sulfonic acid or sulfonic acid derivative of the formulas: Formula (I) or (IV) wherein the variables are as defined herein. These amino lipids may be used in compositions with one or more helper lipids and a nucleic acid therapeutic agent. These compositions may be used to treat a disease or disorder such as cancer, cystic fibrosis, or other genetic diseases.
Patent AU-2017271156-B2 (AU)
Title: A cutting station of a cardboard sheet from a continuous strip of cardboard and a machine for packing an article internally of a cardboard box obtained from the cardboard sheet
Inventor: PONTI GIUSEPPE
IPC: B31B50/16
Filed: 2017-05-16
Granted: 2022-03-17
Abstract: The cutting station (S1) carries out a cutting of a cardboard sheet (F) from a continuous strip of cardboard (S), which continuous strip of cardboard (S) is unwound from a fanfold. The cutting station (S1) comprises: a conveyor plane (1), for advancing the strip of cardboard (S); conveying means (2), for advancing the continuous strip of cardboard (S) along the conveyor plane (1) and for halting the continuous strip of cardboard (S) for enabling cutting thereof; a cutting group (3), predisposed above the conveyor plane (1), and comprising a first rotary circular blade (31) and a toothed second rotary circular blade (32). The cutting group (3) is mounted above the conveyor plane (1) so as to be movable in alternating translation transversally to the conveyor plane (1). The first rotary circular blade (32) is mounted so that the cutting profile thereof passes beyond the conveyor plane (1) at a transversal channel (33), so as to be able to cut the continuous strip of cardboard (S) and obtain a cardboard sheet (F), the toothed second rotary circular blade (32) is mounted so that the cutting profile thereof contacts the continuous strip of cardboard (S) without passing beyond it so as to realise thereon a transversal score line (T4).
Patent AU-2017274078-B2 (AU)
Title: An improved apparatus for hanging doors
Inventor: HAYES ROBERT STANLEY
IPC: B62B3/06
Filed: 2017-05-30
Granted: 2021-10-14
Abstract: A door hanging apparatus includes a base for ground contact. A height adjustment bracket is located above the base and includes a lifting platform for supporting an underside of a door. A leadscrew assembly, including a leadscrew, interconnects the base and the height adjustment bracket. The leadscrew assembly operates to vary spacing between the base and the height adjustment bracket in response to rotation of the leadscrew.
Patent AU-2017291507-B2 (AU)
Title: Syringe stabilizer
Inventor: ARIAGNO SCOTT RICHARD
IPC: A61M5/315
Filed: 2017-06-26
Granted: 2021-02-18
Abstract: A syringe stabilizing apparatus has a base and a syringe support. The syringe support is vertically disposed above the base, elevating a fluid-filled portion of an infusion set vertically above the base and orienting a delivery end of the fluid-filled portion upwardly relative to a horizontal plane to take advantage of a gravitational effect on a fluid during delivery of the fluid from the fluid-filled portion to a patient. The syringe support comprises a first retainer and a selectively actuated tube clamp. The first retainer has an opening in which a rigid portion of the infusion set is received and retained therein without further user intervention. The selectively actuated tube clamp is operatively aligned with the first retainer wherein a flexible tube extending from the rigid portion of the infusion set extends through the tube clamp.